Karyopharm Therapeutics Inc.
KPTI
$5.40
$0.459.09%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -43.21% | -35.90% | -35.75% | -42.94% | -31.13% |
| Total Receivables | 10.03% | -16.20% | 0.82% | -11.70% | -49.05% |
| Inventory | 55.73% | 50.47% | -5.34% | -27.65% | -27.96% |
| Prepaid Expenses | 13.24% | 10.59% | 18.32% | -15.35% | -10.05% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -95.45% | -93.94% | -94.36% | -45.74% | -37.97% |
| Total Current Assets | -33.10% | -29.81% | -28.43% | -37.73% | -33.20% |
|
|
|||||
| Total Current Assets | -33.10% | -29.81% | -28.43% | -37.73% | -33.20% |
| Net Property, Plant & Equipment | 28.72% | -43.80% | -37.33% | -32.77% | -33.82% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.43% | 30.57% | 323.26% | 158.36% | 158.29% |
| Total Assets | -31.62% | -29.81% | -28.15% | -37.24% | -32.87% |
|
|
|||||
| Total Accounts Payable | 63.53% | 513.26% | 22.30% | -44.41% | 12.62% |
| Total Accrued Expenses | -1.21% | -10.07% | -3.86% | 16.62% | 5.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -86.76% | 14.80% | 14.95% | 15.05% | 15.18% |
| Total Finance Division Other Current Liabilities | -0.79% | -13.06% | -16.07% | -18.55% | -10.50% |
| Total Other Current Liabilities | -0.79% | -13.06% | -16.07% | -18.55% | -10.50% |
| Total Current Liabilities | 32.79% | -0.94% | -2.22% | 6.15% | 5.42% |
|
|
|||||
| Total Current Liabilities | 32.79% | -0.94% | -2.22% | 6.15% | 5.42% |
| Long-Term Debt | -22.07% | -12.89% | -12.73% | 0.19% | 0.19% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 140.66% | -- | -78.78% | -64.52% | -54.26% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1,434.97% | 1,548.39% | 840.99% | 137.97% | -- |
| Total Liabilities | -6.96% | -5.73% | -6.22% | 0.66% | 0.48% |
|
|
|||||
| Common Stock & APIC | 1.98% | 2.06% | 2.15% | 1.70% | 1.74% |
| Retained Earnings | -5.14% | -6.05% | -6.37% | -10.62% | -10.65% |
| Treasury Stock & Other | -121.12% | 70.08% | 22.73% | -23.63% | 74.76% |
| Total Common Equity | -36.57% | -59.02% | -85.46% | -274.01% | -717.76% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -36.57% | -59.02% | -85.46% | -274.01% | -717.76% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -36.57% | -59.02% | -85.46% | -274.01% | -717.76% |
|
|
|||||